Mode
Text Size
Log in / Sign up
N/A N=19 Basic Science

Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease

Parkinson's Disease

Enrolled (actual)
19
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Gait Speed (m/s) — 1.14; 1.21; 1.22; 1.20 m/s

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Gait training (Other)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Gait Speed (m/s)
1.14; 1.21; 1.22; 1.20
PRIMARY
Montreal Cognitive Assessment Score
27.1; 27.7

Summary

The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecting more than 80,000 Veterans, a major health issue in the Veterans' health system. Mobility and cognitive limitations are a common problem in PD and are associated with significant disability, increased fall risk, reduced quality of life, and increased caregiver burden. While less is known about its benefit on cognition, physical therapy has proven to be an effective treatment to mitigate mobility limitations, though the response to rehabilitation interventions is highly variable. The proposed research will inform the investigators' understanding of the impact of certain genetic profiles associated with learning impairments on motor and cognitive benefits in response to gait rehabilitation, and will provide an important foundation for more personalized and improved gait rehabilitation programs for different subgroups of PD patients.

Eligibility Criteria

Inclusion Criteria

  • Meet UK Brain Bank (UKBB) criteria for the diagnosis of PD (modified so that having more than one affected relative was not considered an exclusion criteria)
  • Have a Hoehn & Yahr score of 3
  • Have the ability to walk 400 m without physical assistance from a device or another person
  • Do not have other health conditions (e.g., orthopedic, cardiopulmonary) that impact the ability to safely participate in a moderately intense gait training program

Exclusion Criteria

  • The investigators will exclude those patients presenting clinical diagnosis of dementia.
  • The investigators will exclude those patients presenting conditions (cardiac, renal, or metabolic) that would pose a risk to their health by exercising.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03607695). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search